Showing results (931-940 of 4,215) with videos related to
Sort By:
Pageof 422
Discover Oncology|June 3, 2026
Single-cell data analysis of lung cancer brain metastasis reveals SEC61G serves as a potential risk indicatorYunjing Li, Yuanyuan Zhang, Wenxin Tian, et al.Discover Oncology|June 4, 2026
Ferroptosis-related gene EPAS1 suppresses breast cancer progression by inhibiting M2 macrophage polarizationZhaoneng Lin, Yongshun Li, Yuzhen Shi, et al.Discover Oncology|June 8, 2026
A bibliometric analysis of extrachromosomal DNA in cancer over six decadesQiqi Luo, Nan Zhou, Chuanfang Wu, et al.Discover Oncology|June 8, 2026
Landscape and biogenesis of piRNAs in HBV-associated hepatocarcinogenesis: from repetitive elements to oncogenic circuitsXuying Chen, Yong Zhu, Yingke Xu, et al.Discover Oncology|June 7, 2026
Hypomethylation of FAM83A in lung adenocarcinoma mirrors an epigenetic signature of airway cell differentiation statesCamille Wangermez, Francois M Carlier, Marylène Lecocq, et al.Discover Oncology|June 6, 2026
GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinomaZixu Wang, Jiang Fu, Shengjie Tang, et al.Discover Oncology|June 6, 2026
Hsa_circ_0000231 activates the MAPK pathway via IGF2BP2-mediated CACNA1H mRNA stabilization to promote cervical cancer progressionShaofeng Ma, Jianbiao Lin, Xueli Deng, et al.Discover Oncology|July 1, 2023
Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathwayJinshui Tan, Mengya Zhong, Yanyan Hu, et al.Discover Oncology|June 28, 2023
Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinomaYizheng Xue, Tianyi Chen, Naiqiao Hou, et al.Discover Oncology|July 31, 2023
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistanceYi Zhang, Wendong Gu, Yingjie ShaoPageof 422